DOI
10.21143/jhp.vol51.no4.3302
Abstract
The Covid-19 vaccine is expected to be a solution to return to normal life. However, the need for vaccines that are global in nature raises several questions in the community, especially regarding the existence of patent protection. For this reason, this paper will answer these questions by discussing the patentability of the Covid-19 vaccine as well as how to implement patent protection in the midst of a pandemic and public concerns about limited access to vaccines. The research method used in the writing of this thesis is normative juridical with a qualitative approach where the data comes from literature studies and interviews. Based on the author's research, the author came to the conclusion that the Covid-19 vaccine can obtain patent protection as long as a patent application has been submitted to the patent office in which the vaccine meets all the patentability requirements. Due to the absence of an international patent protection mechanism, patent applications must be filed in many countries to maximize the scope of patent protection areas.
Bahasa Abstract
Vaksin Covid-19 diharapkan dapat menjadi solusi untuk kembali hidup normal. Namun, kebutuhan vaksin yang bersifat global menimbulkan beberapa pertanyaan di masyarakat, khususnya terkait eksistensi perlindungan paten. Untuk itu, penulisan ini akan menjawab pertanyaan-pertanyaan tersebut dengan membahas patentabilitas vaksin Covid-19 serta bagaimana cara pelaksanaan perlindungan paten di tengah pandemi dan kekhawatiran masyarakat akan keterbatasan akses terhadap vaksin. Metode penelitian yang digunakan dalam penulisan skripsi ini adalah yuridis normatif dengan pendekatan kualitatif di mana data-data berasal dari studi pustaka dan wawancara. Berdasarkan penelitian Penulis, Penulis sampai pada simpulan bahwa vaksin Covid-19 dapat memperoleh perlindungan paten selama permohonan akan paten telah diajukan kepada kantor paten di mana vaksin telah memenuhi seluruh persyaratan patentabilitas. Dikarenakan tidak adanya mekanisme perlindungan paten secara internasional, permohonan paten harus diajukan di banyak negara untuk memaksimalkan cakupan wilayah perlindungan paten.
References
Buku Bloeman, Sophie dan Thomas de Groot. Eds. Our Commons: Political Ideas for a New Europe. Amsterdam: Institute of Network Cultures, 2019. Correa, Carlos M. Guide for the Application and Granting of Compulsory Licenses and Authorization of Government Use of Pharmaceutical Patents. Switzerland: WHO, 2009. Correa, Carlos M. Guidelines for the examination of patent applications relating to pharmaceuticals [S.l.: United Nations Development Programme, s.a.]. Dratler, Jay. Intellectual Property Law: Commercial, Creative, and Industrial Property. New York: Law Journal Press, 2006. Dapat diakses di https://books.google.co.id/books?id=-gLuY2rBU9oC&pg=RA4-PA106&dq=first+to+file+patent&hl=en&sa=X&ved=2ahUKEwikgsTbi8HsAhXmILcAHWI6D-MQ6AEwCHoECAUQAg#v=onepage&q=first%20to%20 file%20patent&f=false. Sardjono, Agus. Riset Hukum: Sebuah Novel Tentang Metode Penelitian Hukum. Ed. 1. Cet. 1. Depok: Murai Kencana, 2019. Soekanto, Soerjono, Pengantar Penelitian Hukum. Cet. 3. Jakarta: Penerbit Universitas Indonesia (UI Press): 1986. OECD. OECD Patent Statistics Manual. S.l.: OECD, 2009. Viksnins, Ann S. dan Ann M. McCrackin. “A Guide to International Patent Protection.” Dalam Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices. Oxford: MIHR, 2007. World Health Organization. Country experiences in using TRIPS safeguards: Part I. S.l.: World Health Organization, 2017. World Intellectual Property Organization. Intellectual Property Basics: A Q&A for Students. Cina: CNIPA dan WIPO, 2019. World Intellectual Property Organization. Understanding Industrial Property. Ed. Switzerland: WIPO, 2016. World Intellectual Property Organization. WIPO Guide to Using Patent Information. S.l.: s.n, s.a. Dapat diakses melalui https://www.wipo.int/edocs/ pubdocs/en/wipo_pub_l434_3.pdf. Dokumen Internasional U.S. Department of Justice and the Federal Trade Commission, Antitrust Guidelines for the Licensing of Intellectual Property (Januari 2017). World Health Organization. Emergeny Use Listing Procedure (13 Desember 2020). World Intellectual Property Organization. PCT Applicant’s Guide – National Phase, Chapter 2: Entry into the National Phase (General). Dapat diakses melalui https://www.wipo.int/pct/en/guide/np02.html#_chapt2. World Intellectual Property Organization. STANDING COMMITTEE ON THE LAW OF PATENTS Ninth Session. SCP/9/5 (2003). World Trade Organization. AGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS (TRIPs). World Intellectual Property Organization. Regulations under the Patent Cooperation Treaty (2020). Eksistensi Perlindungan Paten: Adzhani Tharifah, Agus Sardjono 1101 Internet AFD China Intellectual Property Law Office. “Brief introduction of the patent priority system.” https://www.lexology.com/library/detail.aspx?g=ffa0ecae-c84c-4fa0-b62b-2df59f67e825. Diakses 29 Desember 2020. Bird & Bird. “Patents: no supplementary protection certificate for second medical use.” https://www.twobirds.com/en/news/articles/2020/global/no-supplementary-protection-certificate-for-second-medical-use. Diakses 29 Desember 2020. Brachman, Steve. “WHO’s C-TAP Initiative Pushes for Non-Exclusive Global Licensing Amid Pharma Industry Concerns.” https://www.ipwatchdog.com/2020/05/31/whos-c-tap-initiative-pushes-non-exclusive-global-licensing-amid-pharmaceutical-industry-concerns/id=122041/. Diakses 15 November 2020. Carbonell, Enric. “What you should know on the right of priority for patents. A European perspective.” https://abg-ip.com/right-priority-for-patents/. Diakses 29 Desember 2020. Christie, Andrew. “Why We Should Grant Patents on Covid-19 Vaccines.” https://pursuit.unimelb.edu.au/articles/why-we-should-grant-patents-on-covid-19-vaccines. Diakses 21 Desember 2020. Direktorat Jenderal Kekayaan Intelektual. “Bagaimana cara mengajukan permohonan Paten?” https://dgip.go.id/32-paten. Diakses 21 Oktober 2020. European Commission. “Supplementary protection certificates for pharmaceutical and plant protection products.” https://ec.europa.eu/growth/industry/policy/intellectual-property/patents/supplementary-protection-certificates_en. Diakses 29 Desember 2020. European Patent Office. “Indonesia: Amendments to IP laws.” https://www.epo.org/searching-for-patents/helpful-resources/asian/asia-updates/2020/20201126.html. Diakses 9 Desember 2020. Hoen, Ellen ‘t. “The Medicines Patent Pool.” https://haiweb.org/wp-content/uploads/2020/01/The-Medicines-Patent-Pool.pdf. Dakses 21 November 2020. Medecins Sans Frontieres. “MSF: Moderna’s decision to not enforce COVID-19 vaccine patents during the pandemic isn’t enough.” https://www.doctorswithoutborders.org/what-we-do/news-stories/news/msf-modernas-decision-not-enforce-covid-19-vaccine-patents-during. Diakses 21 Desember 2020. Medicines Patent Pool. “Licenses.” https://medicinespatentpool.org/progress-achievements/licences/. Diakses 16 Desember 2020. Rospatent Federal Service of Intellectual Property. “COVID-19 vaccines, a robot surgeon, biofuels and a new polymer material. What promising inventions were patented by Russian developers in 9 months of 2020.” https://rospatent.gov.ru/ru/news/promising-inventions-9m2020. Diakses 5 Desember 2020. Rutz, Berthold dan Siobhán Yeats. “The importance of being inventive.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298979/. Diakses 19 Oktober 2020. 1102 Jurnal Hukum & Pembangunan Tahun ke-51 No.4 Oktober-Nopember 2021 RWS: insights. “The Paris Convention versus the PCT.” https://www.rws.com/insights/the-paris-convention-versus-the-pct/. Diakses 1 November 2020. The Guardian. “Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows.” https://www.theguardian.com/world/2020/nov/18/pfizer-covid-19-vaccine-95-effective-and-safe-further-tests-show. Diakses 21 Desember 2020. U.S. Food & Drug Administration. “FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine.” https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid. Diakses 30 Desember 2020. Venner, Julia. “Second Medical Uses at the EPO.” https://www.lexology.com/library/detail.aspx?g=c4eb8946-64cd-461d-bbb0-369313d4b793. Diakses 24 Desember 2020. World Health Organization. “Archived: WHO Timeline - COVID-19,” https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19. Diakses 4 Juli 2020. World Health Organization. “International community rallies to support open research and science to fight COVID-19.” https://www.who.int/news/item/29-05-2020-international-community-rallies-to-support-open-research-and-science-to-fight-covid-19. Diakses 18 November 2020. World Intellectual Property Organization. “Direct filing of PCT application with the International Bureau as PCT Receiving Office (RO/IB).” https://www.wipo.int/pct/en/filing/filing.html. Diakses 21 Oktober 2020. World Intellectual Property Organization. “PATENT POOLS AND ANTITRUST – A COMPARATIVE ANALYSIS.” (Maret 2014). Hlm. 3. Dapat diakses melalui https://www.wipo.int/export/sites/www/ip-competition/en/studies/patent_pools_ report.pdf. World Intellectual Property Organization. “PCT FAQs: Protecting your Inventions Abroad: Frequently Asked Questions About the Patent Cooperation Treaty (PCT).” https://www.wipo.int/pct/en/faqs/faqs.html. Diakses 16 Juli 2020. World Intellectual Property Organization. “The PCT now has 153 Contracting States,” https://www.wipo.int/pct/en/pct_contracting_states.html. Diakses 21 Desember 2020. Worley, William. “COVID-19 puts a spotlight on the Medicines Patent Pool.” https://www.devex.com/news/covid-19-puts-a-spotlight-on-the-medicines-patent-pool-97461. Diakses 14 November 2020. Zimmer, Carl, Jonathan Corum dan Sul-Lee Wee. “Coronavirus Vaccine Tracker.” https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html. Diakses 14 Februari 2020. Zultan, Rochmali dan Indah Handayani. “Using the New Online IP Filing System in Indonesia.” https://www.tilleke.com/resources/using-new-online-ip-filing-system-indonesia. Diakses 20 Oktober 2020. _____. “Pendaftaran Paten Obat Covid-19 Bisa Dilakukan Tanpa Mengorbankan Kepentingan Umum.” https://en.dgip.go.id/pendaftaran-paten-obat-covid-19-bisa-dilakukan-tanpa-mengorbankan-kepentingan-umum. Diakses 2 November 2020. Eksistensi Perlindungan Paten: Adzhani Tharifah, Agus Sardjono 1103 Jurnal Adams, Stephen R. “Regional Patent Systems: A Challenge for the International Searcher.” Science & Technology Libraries 22 (2001). Hlm. 90. DeRoo, Pier. “Public Non-Commercial Use' Compulsory Licensing for Pharmaceutical Drugs in Go Pharmaceutical Drugs in Government Health Car ernment Health Care Programs.” Michigan Journal of International Law 32 (2011). Hlm. 351. Doi, Terui. “The Territoriality Principle of Patent Protection and Conflict of Laws: A Review of Japanese Court Decisions.” Fordham International Law Journal 26 (2002). Hlm. 378-379. E, Asif. “Exclusion of Diagnostic, Therapeutic and Surgical Methods from Patentability.” Journal of Intellectual Property Rights 18 (Mei 2013). Hlm. 244. Hu, Weinian. “Compulsory Licensing and Access to Future Covid-19 Vaccines.” CEPS Research Report 2020/02 (Juli 2020). Hlm. 1. Maskus, Keith E. “Intellectual Property Rights and Economic Development.” Case Western Reserve Journal of International Law 32 (2000). Hlm. 474. Müller, Mareike Sophie. “Licensing Terms and Effectiveness of the Medicines Patent Pool,” Ausgewählte Abschlussarbeiten (2013). Hlm. 76. Nair, Ramkumar Balachandra dan Pratap Chandran Ramachandranna. “Patenting of microorganisms: Systems and concerns.” Journal of Commercial Biotechnology 16 (2010). Hlm. 339. Raju, K D. “Compulsory v Voluntary Licensing: A Legitimate way to Enhance Access to Essential Medicines in Developing Countries.” Journal of Intellectual Property Rights 22 (Januari 2017). Hlm. 28. Sardjono, Agus. “Patent, Technology, and the Role of University.” Indonesia Law Review 1 (April 2013). Hlm. 22. Ulrich, Lauren. “TRIPS and Compulsory Licensing: Increasing Participation in the Medicines Patent Pool in the Wake of an HIV/AIDS Treatment Timebomb.” Emory International Law Review 30 (2015). Hlm. 60-61. Peraturan Perundang-Undangan Indonesia. Undang-Undang Cipta Kerja. UU No. 11 Tahun 2020, LN No. 245 Tahun 2020. TLN No. 6673. Indonesia. Undang-Undang Paten. UU No. 13 Tahun 2016. LN No. 176 Tahun 2016. TLN No. 5922
Recommended Citation
Tharifah, Adzhani and Sardjono, Agus
(2021)
"EKSISTENSI PERLINDUNGAN PATEN ATAS VAKSIN COVID-19,"
Jurnal Hukum & Pembangunan: Vol. 51:
No.
4, Article 13.
DOI: 10.21143/jhp.vol51.no4.3302
Available at:
https://scholarhub.ui.ac.id/jhp/vol51/iss4/13
Included in
Administrative Law Commons, Comparative and Foreign Law Commons, Health Law and Policy Commons